100 related articles for article (PubMed ID: 8880216)
1. Generation and application of monoclonal antibody to human pancreatic carcinoma.
Yuan S; Zhang H; Chen Q
Hybridoma; 1996 Aug; 15(4):289-93. PubMed ID: 8880216
[TBL] [Abstract][Full Text] [Related]
2. Radioimmunolocalization of human pancreatic carcinoma xenograft by 99mTc-labeled YPC3 monoclonal antibody.
Chen Q; Yuan S
J Cancer Res Clin Oncol; 1994; 120(11):668-71. PubMed ID: 7962043
[TBL] [Abstract][Full Text] [Related]
3. [The anti-pancreatic cancer efficacy of LAK cells mediated by YPC3 monoclonal antibody in vitro and in vivo].
Chen QK; Yuan SZ
Zhonghua Zhong Liu Za Zhi; 1994 Sep; 16(5):353-5. PubMed ID: 7895586
[TBL] [Abstract][Full Text] [Related]
4. [Immunotherapy of advanced pancreatic carcinoma with the monoclonal antibody BW 494].
Büchler M; Kübel R; Malfertheiner P; Friess H; Schulz G; Bosslet K; Beger HG
Dtsch Med Wochenschr; 1988 Mar; 113(10):374-80. PubMed ID: 3349938
[TBL] [Abstract][Full Text] [Related]
5. Potential usefulness of 99mTc-labeled monoclonal antibody A7 for immunoscintigraphy of human pancreatic carcinoma.
Matsumura H; Otsuji E; Kobayashi S; Okamoto K; Toma A; Yamagishi H
Anticancer Res; 2001; 21(5):3433-7. PubMed ID: 11848505
[TBL] [Abstract][Full Text] [Related]
6. Human pancreatic cancer-associated antigens detected by murine monoclonal antibodies.
Yuan SZ; Ho JJ; Yuan M; Kim YS
Cancer Res; 1985 Dec; 45(12 Pt 1):6179-87. PubMed ID: 4063969
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic tumor antigens: diagnostic markers and targets for immunotherapy.
Finn OJ
Important Adv Oncol; 1992; ():61-77. PubMed ID: 1374733
[No Abstract] [Full Text] [Related]
8. [Immunoscintigraphy of anti-type IV collagenase monoclonal antibody in nude mice bearing human lung cancer xenograft].
Dai Y; Jia B; Wang F; Du J; Shang BY; Zhen YS
Ai Zheng; 2003 Dec; 22(12):1243-8. PubMed ID: 14693044
[TBL] [Abstract][Full Text] [Related]
9. Binding and functional properties of a mouse-human chimeric monoclonal antibody of the human IgG1 subclass with specificity for human carcinomas.
Liao SK; Horton L; Flahart RE; O'Rear L; Crumpacker D; Imbaratto JW; Yannelli JR; Robinson RR; Oldham RK
Hum Antibodies Hybridomas; 1990; 1(2):66-76. PubMed ID: 2103354
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of growth of colorectal carcinoma in nude mice by monoclonal antibody.
Herlyn DM; Steplewski Z; Herlyn MF; Koprowski H
Cancer Res; 1980 Mar; 40(3):717-21. PubMed ID: 7471090
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody with binding and inhibiting activity towards human pancreatic carcinoma cells. I. Immunohistological and immunochemical characterization of a murine monoclonal antibody selecting for well differentiated adenocarcinomas of the pancreas.
Bosslet K; Kern HF; Kanzy EJ; Steinstraesser A; Schwarz A; Lüben G; Schorlemmer HU; Sedlacek HH
Cancer Immunol Immunother; 1986; 23(3):185-91. PubMed ID: 3539336
[TBL] [Abstract][Full Text] [Related]
12. Comparison of methods for the generation of immunoreactive fragments of a monoclonal antibody (B72.3) reactive with human carcinomas.
Milenic DE; Esteban JM; Colcher D
J Immunol Methods; 1989 Jun; 120(1):71-83. PubMed ID: 2499638
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evaluation of monoclonal antibody 14C5 for targeting pancreatic cancer.
Vervoort L; Burvenich I; Staelens S; Dumolyn C; Waegemans E; Van Steenkiste M; Baird SK; Scott AM; De Vos F
Cancer Biother Radiopharm; 2010 Apr; 25(2):193-205. PubMed ID: 20423233
[TBL] [Abstract][Full Text] [Related]
14. Comparative binding and preclinical localization and therapy studies with radiolabeled human chimeric and murine 17-1A monoclonal antibodies.
Buchsbaum DJ; Brubaker PG; Hanna DE; Glatfelter AA; Terry VH; Guilbault DM; Steplewski Z
Cancer Res; 1990 Feb; 50(3 Suppl):993s-999s. PubMed ID: 2297753
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy of human ovarian carcinoma with OvaRex MAb-B43.13 in a human-PBL-SCID/BG mouse model.
Schultes BC; Zhang C; Xue LY; Noujaim AA; Madiyalakan R
Hybridoma; 1999 Feb; 18(1):47-55. PubMed ID: 10211788
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody recognizing a carcinoembryonic antigen epitope differentially expressed in human colonic carcinoma versus normal adult colon tissues.
Zhang HZ; Ordonez NG; Batsakis JG; Chan JC
Cancer Res; 1989 Oct; 49(20):5766-73. PubMed ID: 2477148
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoscintigraphy and radioimmunotherapy of renal cell carcinoma xenografts.
Vessella RL; Alvarez V; Chiou RK; Rodwell J; Elson M; Palme D; Shafer R; Lange P
NCI Monogr; 1987; (3):159-67. PubMed ID: 3821914
[TBL] [Abstract][Full Text] [Related]
18. Cell binding and tumor inhibiting functions of a new antihuman melanoma murine monoclonal antibody.
Abdel-Wahab Z; Darrow T; Vervaert CE; Crowley NJ; Seigler HF
Mol Biother; 1991 Sep; 3(3):163-9. PubMed ID: 1768367
[TBL] [Abstract][Full Text] [Related]
19. BIS-1: a novel bispecific monoclonal antibody for CEA-expressing carcinoma radioimmunoscintigraphy and radioimmunotherapy.
Parisi A; Bartolazzi A; Bonino C; Camagna M; DeMonte LB; Lombardi A; Natali PG; Paganelli G; Tarditi L; Vassarotto C
Year Immunol; 1993; 7():96-105. PubMed ID: 8372516
[No Abstract] [Full Text] [Related]
20. A novel bispecific, trivalent antibody construct for targeting pancreatic carcinoma.
Gold DV; Goldenberg DM; Karacay H; Rossi EA; Chang CH; Cardillo TM; McBride WJ; Sharkey RM
Cancer Res; 2008 Jun; 68(12):4819-26. PubMed ID: 18559529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
